Pneumococcal pneumonia and endotoxemia: An experimental and clinical reappraisal
European Journal of Clinical Investigation · 2024
DOI: 10.1111/eci.14077 ↗Kurz gefasst
Leserbrief in der Zeitschrift European Journal of Clinical Investigation, 2024. Verfasst von Jeanne Godon und 13 weiteren Autor:innen. Beteiligte Einrichtung: Department of Infectious Diseases, Dijon-Bourgogne University Hospital, Dijon, France. Hauptthemen laut MEDLINE: Pneumonia, Pneumococcal, Endotoxemia. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 15 Literaturangaben. Gefördert von: (PHRC) 2004/37 (HyaloStrepto project), AOI (Appel d'Offre Interne) from the University hospital of Dijon, INSERM (Institut National de la Sante et de la Recherche Medicale - Center de Recherche UMR 1231, Dijon, France), the national research agency (ANR) Investisse….
Abstract (Originalsprache)
Background
Circulating endotoxins could result from bacterial digestive translocation during sepsis, thus contributing to uncontrolled systemic inflammation, leading in turn to organ dysfunction. We addressed this issue in the setting of severe pneumococcal pneumonia.
Methods
Endotoxemia was measured in a clinically relevant rabbit model of ventilated pneumococcal pneumonia and in 110 patients with bacteraemic pneumonia, using a patented mass spectrometry (LC–MS/MS) method for detection of 3‐OH fatty acids (C10, C12, C14, C16 and C18), which are molecules bound to the lipid A motif of LPS.
Results
Whereas higher levels of systemic inflammation and organ dysfunctions were found, there was no significant difference in lipopolysaccharide concentrations when infected rabbits were compared to non‐infected ones, or when patients were compared to healthy volunteers.
Conclusions
Seemingly, endotoxins do not drive the overwhelming inflammation associated with severe forms of pneumococcal pneumonia.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Infectious Diseases, Dijon-Bourgogne University Hospital, Dijon, France.
- Department of Intensive Care, Dijon-Bourgogne University Hospital, Dijon, France.
- Lipness Team, INSERM Research Centre LNC-UMR1231 and LabEx LipSTIC, University of Burgundy, Dijon, France.
- Lipidomic Analytic Platform, Dijon, France.
- Laboratory of bacteriology, Dijon-Bourgogne University Hospital, Dijon, France.
- CHU Dijon-Bourgogne, INSERM, Université de Bourgogne CIC 1432 Module Épidémiologie Clinique, Dijon France and LabEx LipSTIC, University of Burgundy, Dijon, France.
ORCID-Profile: Mathieu Blot
Förderung
- (PHRC) 2004/37 (HyaloStrepto project)
- AOI (Appel d'Offre Interne) from the University hospital of Dijon
- INSERM (Institut National de la Sante et de la Recherche Medicale - Center de Recherche UMR 1231, Dijon, France), the national research agency (ANR) Investisse…
- MSD-Avenir 2018 (Paris, France; sponsorship agreement) (experimental project)
Zitieren
APA
Godon, J., Charles, P. E., Nguyen, S., de Barros, J. P., Choubley, H., Jacquier, M., Tetu, J., Quenot, J. P., Luu, M., Binquet, C., Masson, D., Piroth, L., Blot, M., & Pneumotoxemia study group (2024). Pneumococcal pneumonia and endotoxemia: An experimental and clinical reappraisal. European Journal of Clinical Investigation. https://doi.org/10.1111/eci.14077
Vancouver
Godon J, Charles PE, Nguyen S, de Barros JP, Choubley H, Jacquier M, et al. Pneumococcal pneumonia and endotoxemia: An experimental and clinical reappraisal. European Journal of Clinical Investigation. 2024. doi:10.1111/eci.14077
BibTeX
@article{Godon2024,
author = {Godon, Jeanne and Charles, Pierre-Emmanuel and Nguyen, Sylvie and de Barros, Jean-Paul Pais and Choubley, Hélène and Jacquier, Marine and Tetu, Jennifer and Quenot, Jean-Pierre and Luu, Maxime and Binquet, Christine and Masson, David and Piroth, Lionel and Blot, Mathieu and Pneumotoxemia study group, Pneumotoxemia study group},
title = {Pneumococcal pneumonia and endotoxemia: An experimental and clinical reappraisal},
journal = {European Journal of Clinical Investigation},
year = {2024},
doi = {10.1111/eci.14077}
}
EUVIMED